Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9-Reference-Cited by-同舟云学术

Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9

Published:2022-04-10 Issue:8 Volume:29 Page:5007-5019
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Ono Masato,Ono Yusuke,Nakamura Toru,Tsuchikawa Takahiro,Kuraya Tomotaka,Kuwabara Shota,Nakanishi Yoshitsugu,Asano Toshimichi,Matsui Aya,Tanaka Kimitaka,Ebihara Yuma,Kurashima Yo,Noji Takehiro,Murakami Soichi,Shichinohe Toshiaki,Mitsuhashi Tomoko,Omori Yuko,Furukawa Toru,Taniue Kenzui,Suzuki Mayumi,Sugitani Ayumu,Karasaki Hidenori,Mizukami Yusuke^ORCID,Hirano Satoshi

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-022-11630-0.pdf

Reference42 articles.

1. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21.

2. Majumder S, Philip NA, Singh Nagpal SJ, et al. High-grade dysplasia in resected main-duct intraductal papillary mucinous neoplasm (MD-IPMN) is associated with an increased risk of subsequent pancreatic cancer. Am J Gastroenterol. 2019;114(3):524–9.

3. McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–61.